Vnitr Lek 2019, 65(12):802-808 | DOI: 10.36290/vnl.2019.139

Pharmacologically induced thyreopathy in patients with cardiovascular disease

Tomáš Brutvan*, Jan Krátký, Jana Ježková
III. interní klinika - endokrinologie a metabolismu 1. LF UK a VFN v Praze

Thyroid gland function is mediated by thyreoideal hormones, in which iodine is very important structural part. High iodine intake, can initiate thyroid dysfunction. Amiodarone induced hypothyroidism is treated with levothyroxine and amiodarone taking is not interrupted. Amiodarone induced hyperthyroidism is divided into two subtypes, which differ by mechanism of origin and treatment strategy. In patients with cardiovascular disease is higher possibility of getting substances, with high content of iodine in diagnostic-therapeutic examination with contrast or treatment with amiodarone. In this group of patients is necessary to control thyroid function regularly and to hold preventive actions.

Keywords: amiodarone; hyperthyroidism; hypothyroidism; iodine; thyroid dysfunction

Received: October 14, 2019; Accepted: November 12, 2019; Published: December 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Brutvan T, Krátký J, Ježková J. Pharmacologically induced thyreopathy in patients with cardiovascular disease. Vnitr Lek. 2019;65(12):802-808. doi: 10.36290/vnl.2019.139.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Marek J, Hána V (eds). Endokrinologie. Galén: Praha 2017. ISBN 978-80-7262-484-3.
    2. Wolff J, Chaikoff IL. Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem 1948; 174(2): 555-564. Go to original source...
    3. Reiners C, Wegscheider K, Schicha H et al. Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid 2004; 14(11): 926-932. Dostupné z DOI: <http://dx.doi.org/10.1089/thy.2004.14.926>. Go to original source... Go to PubMed...
    4. O'Brien T, Dinneen SF, O'Brien PC et al. Hyperlipidemia in patients with primary and secondary hypothyroidism. Mayo Clin Proc 1993; 68(9): 860-866. Dostupné z DOI: <http://dx.doi.org/10.1016/s0025-6196(12)60694-6>. Go to original source... Go to PubMed...
    5. Frost L, Vestergaard P, Mosekilde L. Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Arch Intern Med 2004; 164(15): 1675-1678. Dostupné z DOI: <http://dx.doi.org/10.1001/archinte.164.15.1675>. Erratum in Arch Intern Med 2005; 165(3): 307. Go to original source... Go to PubMed...
    6. Stern RA, Robinson B, Thorner AR et al. A survey study of neuropsychiatric complaints in patients with Graves' disease. J Neuropsychiatry Clin Neurosci 1996; 8(2): 181-185. Dostupné z DOI: <http://dx.doi.org/10.1176/jnp.8.2.181>. Go to original source... Go to PubMed...
    7. Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996; 379(6564): 458-460. Dostupné z DOI: <http://dx.doi.org/10.1038/379458a0>. Go to original source... Go to PubMed...
    8. Eng PH, Cardona GR, Fang SL et al. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology 1999; 140(8): 3404-3410. Dostupné z DOI: <http://dx.doi.org/10.1210/endo.140.8.6893>. Go to original source... Go to PubMed...
    9. Saberi M, Utiger RD. Augmentation of thyrotropin responses to thyrotropinreleasing hormone following small decreases in serum thyroid hormone concentrations. J Clin Endocrinol Metab 1975; 40(3): 435-441. Dostupné z DOI: <http://dx.doi.org/10.1210/jcem-40-3-435>. Go to original source... Go to PubMed...
    10. Markou KB, Paraskevopoulou P, Karaiskos KS et al. Hyperthyrotropinemia during iodide administration in normal children and in children born with neonatal transient hypothyroidism. J Clin Endocrinol Metab 2003; 88(2): 617-621. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2002-020681>. Go to original source... Go to PubMed...
    11. Braverman LE. Iodine and the thyroid: 33 years of study. Thyroid 1994; 4(3): 351-356. Dostupné z DOI: <http://dx.doi.org/10.1089/thy.1994.4.351>. Go to original source... Go to PubMed...
    12. Gartner W, Weissel M. Do iodine-containing contrast media induce clinically relevant changes in thyroid function parameters of euthyroid patients within the first week? Thyroid 2004; 14(7): 521-524. Dostupné z DOI: <http://dx.doi.org/10.1089/1050725041517075>. Go to original source... Go to PubMed...
    13. Roti E, Uberti ED. Iodine excess and hyperthyroidism. Thyroid 2001; 11(5): 493-500. Dostupné z DOI: <http://dx.doi.org/10.1089/105072501300176453>. Go to original source... Go to PubMed...
    14. Stanbury JB, Ermans AE, Bourdoux P et al. Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid 1998; 8(1): 83-100. Dostupné z DOI: <http://dx.doi.org/10.1089/thy.1998.8.83>. Go to original source... Go to PubMed...
    15. Rao RH, McCready VR, Spathis GS. Iodine kinetic studies during amiodarone treatment. J Clin Endocrinol Metab 1986; 62(3): 563-568. Dostupné z DOI: <http://dx.doi.org/10.1210/jcem-62-3-563>. Go to original source... Go to PubMed...
    16. Franklyn JA, Davis JR, Gammage MD et al. Amiodarone and thyroid hormone action. Clin Endocrinol (Oxf) 1985; 22(3): 257-264. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365-2265.1985.tb03238.x>. Go to original source... Go to PubMed...
    17. Fradkin JE, Wolff J. Iodide-induced thyrotoxicosis. Medicine (Baltimore) 1983; 62(1): 1-20. Dostupné z DOI: <http://dx.doi.org/10.1097/00005792-198301000-00001>. Go to original source... Go to PubMed...
    18. Lambert M, Unger J, De Nayer P et al. Amiodarone-induced thyrotoxicosis suggestive ofthyroid damage. J Endocrinol Invest 1990; 13(6): 527-530. Dostupné z DOI: <http://dx.doi.org/10.1007/bf03348618 Go to original source... Go to PubMed...
    19. Bartalena L, Grasso L, Brogioni S et al. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 1994; 78(2): 423-427. Dostupné z DOI: <http://dx.doi.org/10.1210/jcem.78.2.8106631>. Go to original source... Go to PubMed...
    20. Brennan MD, Erickson DZ, Carney JA et al. Nongoitrous (type I) amiodaroneassociated thyrotoxicosis: evidence of follicular disruption in vitro and in vivo. Thyroid 1995; 5(3): 177-183. Dostupné z DOI: <http://dx.doi.org/10.1089/thy.1995.5.177>. Go to original source... Go to PubMed...
    21. Smith TJ, Bahn RS, Gorman CA. Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocr Rev 1989; 10(3): 366-391. Dostupné z DOI: <http://dx.doi.org/10.1210/edrv-10-3-366>. Go to original source... Go to PubMed...
    22. Dillmann WH. Biochemical basis of thyroid hormone action in the heart. Am J Med 1990; 88(6): 626-630. Dostupné z DOI: <http://dx.doi.org/10.1016/0002-9343(90)90530-q>. Go to original source... Go to PubMed...
    23. Padovani RP et al. One month is sufficient for urinary iodine to return to its baseline value after the use of water-soluble iodinated contrast agents in post-thyroidectomy patients requiring radioiodine therapy. Thyroid 2012; 22: 926-930. Dostupné z DOI: <http://dx.doi.org/10.1089/thy.2012.0099>. Go to original source... Go to PubMed...
    24. Goldschlager N, Epstein AE, Naccarelli GV et al. A practical guide for clinicians who treat patients with amiodarone: 2007. Heart Rhythm 2007; 4(9): 1250-1259. Dostupné z DOI: <http://dx.doi.org/10.1016/j.hrthm.2007.07.020>. Go to original source... Go to PubMed...
    25. Connolly SJ. Evidence-based analysis of amiodarone efficacy and safety. Circulation 1999; 100(19): 2025. Dostupné z DOI: <http://dx.doi.org/10.1161/01.cir.100.19.2025>. Go to original source... Go to PubMed...
    26. Rhee CM, Bhan I, Alexander EK et al. Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism. Arch Intern Med. 2012; 172(2): 153-159. Dostupné z DOI: <http://dx.doi.org/10.1001/archinternmed.2011.677>. Go to original source... Go to PubMed...
    27. Nimmons GL, Funk GF, Graham MM et al. Urinary iodine excretion after contrast computed tomography scan: implications for radioactive iodine use. JAMA Otolaryngol Head Neck Surg 2013; 139(5): 479-482. Dostupné z DOI: <http://dx.doi.org/10.1001/jamaoto.2013.2552>. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.